[Skip to Content]

Upstate Active Clinical Trials

Study Title:

A Phase 1/2, Randomized, Dose-finding/Dose-confirmation Study to Evaluate the Reactogenicity, Safety and Immuno genicity of mRNA-based Multivalent Season Influenza Vaccine Candidates

What is the purpose of the study? (in Layman's terms, please describe the study)

To study the safety and efficacy of an mRNA-based influenza vaccine

Upstate Institutional Review Board (IRB) Number:

2020089

Study/Protocol ID:

217884

Study Phase:

2

Patient Age Group:

Adults

Principal Investigator:

Stephen J Thomas

What is involved if I participate?

  • How long is the study?
    1 year
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Blood draws, injection with vaccine or placebo

Where will the study take place?

Institute for Global Health and Translational Science, Global Health Research Unit
4900 Broad Rd, POB-North Suite 4U
Syracuse NY 13215

Other Information:

No flu vaccine yet for the 2023-24 season

ClinicalTrials.Gov ID:

NCT05823974

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: William Gregory
Phone: 315-464-5225
Email: gregoryw@upstate.edu

Return to Previous Page || Search Again

Top